Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Seagen Inc (NQ: SGEN )

195.38 +0.71 (+0.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 761,949
Open 194.12
Bid (Size) 192.00 (2)
Ask (Size) 197.83 (1)
Prev. Close 194.67
Today's Range 194.00 - 195.88
52wk Range 116.08 - 207.16
Shares Outstanding 181,934,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Big Pharma is facing a patent cliff that could siphon off billions in revenue. 
Via Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling. 
Via InvestorPlace

Performance

YTD
+51.81%
+51.81%
1 Month
-1.57%
-1.57%
3 Month
+10.17%
+10.17%
6 Month
+61.18%
+61.18%
1 Year
+39.62%
+39.62%

More News

Read More
3 Stocks Worth Buying at 52-Week Lows
Via MarketBeat
Seagen Stockholders Approve Acquisition by Pfizer
From Seagen Inc.
Via Business Wire
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,000 Today
Via Benzinga
Check Out What Whales Are Doing With SGEN
Via Benzinga
(SGEN) - Analyzing Seagen's Short Interest
Via Benzinga
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Via The Motley Fool
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
Via MarketBeat
Topics Bonds
Exposures Debt Markets
FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal
Via Benzinga
$100 Invested In Seagen 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Seagen's Return on Invested Capital Insights
Via Benzinga
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
Via Benzinga
GDC Stock Alert: Why Is GD Culture Group Up 106% Today?
Via InvestorPlace
Why Is Guardforce AI (GFAI) Stock Up Today?
Via InvestorPlace
GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?
Via InvestorPlace
Seagen (SGEN) Stock Falls 6% After Director Sells Shares
Via InvestorPlace
Horizon Tumbles — Taking Seagen, Prometheus With It — On Reports FTC Could Block Its Amgen Takeover
Via Investor's Business Daily
Vaccine Sales Are Falling. Should You Still Buy Pfizer?
Via The Motley Fool
7 High-Yield Dividend Stocks to Buy and Hold Forever
Via InvestorPlace
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
Via Investor's Business Daily
Seagen Reports First Quarter 2023 Financial Results
From Seagen Inc.
Via Business Wire
Earnings Scheduled For April 27, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.